Effects of WuZhi preparations on tacrolimus in pediatric and adult patients carrying the CYP3A5*1 allele of heart transplant during the early period after transplantation
Clinical Transplantation · 2024
DOI: 10.1111/ctr.15237 ↗At a glance
Journal article in Clinical Transplantation, 2024. Written by Li Liu and 8 co-authors. Institution: Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Major MEDLINE topics: Kidney Transplantation, Heart Transplantation, Drugs, Chinese Herbal. Cited 1 times so far (Crossref); 40 references. Funded by: National Key Research and Development Program, National Natural Science Foundation of China, National Basic Research Program of China.
Abstract (original language)
Aim
Wuzhi preparations (WZP) are commonly administrated with tacrolimus (TAC) in China to improve the liver function and increase the exposure of TAC. This study aims to investigate the effects of WZP on TAC in pediatric heart transplantation (HTx) patients carrying the CYP3A5*1 allele during the early period after transplantation and also make a comparison with these effects in adult recipients.
Methods
A total of 81 recipients with CYP3A5*1 allele were included and divided into the pediatric group ( n = 29) and adult group ( n = 52). The changes in TAC dose‐corrected trough blood concentrations (C 0 /D), dose requirement as well as intra‐patient variability(IPV) of C 0 /D after co‐therapy with WZP were evaluated.
Results
The TAC C 0 /D was significantly increased 1.7 and 1.8 times after co‐administration of WZP in the pediatric and adult groups, respectively. We further analyzed the pediatric patients, found that no statistical difference was observed in TAC C 0 /D before and after co‐therapy with WZP in children
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Hubei Province Clinical Research Center for Precision Medicine for Critical Illness, Wuhan, China.
- Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
ORCID profiles: Yu Zhang
Funding
- National Key Research and Development Program
- National Natural Science Foundation of China
- National Basic Research Program of China
Cite
APA
Liu, L., Zhou, Y., Huang, X., Chen, H., Gong, Z., Zhang, J., Zeng, F., Zhou, H., & Zhang, Y. (2024). Effects of WuZhi preparations on tacrolimus in pediatric and adult patients carrying the CYP3A5*1 allele of heart transplant during the early period after transplantation. Clinical Transplantation. https://doi.org/10.1111/ctr.15237
Vancouver
Liu L, Zhou Y, Huang X, Chen H, Gong Z, Zhang J, et al. Effects of WuZhi preparations on tacrolimus in pediatric and adult patients carrying the CYP3A5*1 allele of heart transplant during the early period after transplantation. Clinical Transplantation. 2024. doi:10.1111/ctr.15237
BibTeX
@article{Liu2024,
author = {Liu, Li and Zhou, Ying and Huang, Xiao and Chen, Hefen and Gong, Zhujun and Zhang, Jing and Zeng, Fang and Zhou, Hong and Zhang, Yu},
title = {Effects of WuZhi preparations on tacrolimus in pediatric and adult patients carrying the CYP3A5*1 allele of heart transplant during the early period after transplantation},
journal = {Clinical Transplantation},
year = {2024},
doi = {10.1111/ctr.15237}
}
EUVIMED